KCL Capital’s Hims & Hers Health, Inc. Warrants, each whole warrant exercisable for one Class A Common Stock at an HIMS.WS Stock Holding History

KCL Capital’s Portfolio HIMS.WS Stock Details HIMS.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-12,500	Closed	-$42K	–	79
2021 Q2	$42K	Sell	12,500 -7,500	-38%	-$26.1K	0.01%	62
2021 Q1	$88K	Buy	+20,000	New	+$131K	0.01%	66

KCL Capital's HIMS.WS Position: Q3 2021 in Review

KCL Capital sold out of Hims & Hers Health, Inc. Warrants, each whole warrant exercisable for one Class A Common Stock at an (HIMS.WS) in Q3 2021, closing a stake of 12,500 shares — an estimated $42K sold.

KCL Capital first reported a position in HIMS.WS in Q1 2021 and held it in 2 quarters. The position peaked at $88K in Q1 2021. 0 funds tracked by Wall St. Rank hold HIMS.WS as of Q3 2021.

KCL Capital reported no remaining Hims & Hers Health, Inc. Warrants, each whole warrant exercisable for one Class A Common Stock at an position as of Q3 2021 after selling out during the quarter.
KCL Capital sold 12,500 Hims & Hers Health, Inc. Warrants, each whole warrant exercisable for one Class A Common Stock at an shares in Q3 2021, an estimated $42K.
KCL Capital first reported a position in Hims & Hers Health, Inc. Warrants, each whole warrant exercisable for one Class A Common Stock at an in Q1 2021 and held it in 2 quarters.
KCL Capital's Hims & Hers Health, Inc. Warrants, each whole warrant exercisable for one Class A Common Stock at an position peaked at $88K in Q1 2021.
0 funds tracked by Wall St. Rank held Hims & Hers Health, Inc. Warrants, each whole warrant exercisable for one Class A Common Stock at an as of Q3 2021.

Based on KCL Capital's 13F filing for Q3 2021, filed 15 Nov 2021.